Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific to Attend the International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies.


SAN DIEGO -- Bio-Matrix Scientific Group, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:BMSN BMSN Seaman, Boatswain's Mate Striker (Naval Rating) ), a biotechnology company focused on stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 cryogenics cryogenics: see low-temperature physics.
cryogenics

Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties.
 and disposable stem cell/tissue transfer instruments, announced today that they will be attending the 14th International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies in Las Vegas from December 7-10, 2006.

This is the largest Anti-Aging congress in the United States and this year's event is anticipated to draw over 6,000 participants and 70 plus international speakers. By limiting illness and disability in the latter stages of life, anti-aging medicine can make a quantum leap in people's enjoyment of their later years. This forum will allow companies to seek the latest cutting edge diagnostic and treatment technologies in the competitive medicine arena.

Bio-Matrix will have the opportunity to introduce our medical devices and cryogenic services to Physicians from every Medical Discipline, scientists and pharmaceutical companies. Bio-Matrix will also introduce its new 15,000 sq. ft. state-of-the-art secure Cryogenic Stem Cell Bank, three Research laboratories, aseptic aseptic /asep·tic/ (-tik) free from infection or septic material.

a·sep·tic
adj.
Of, relating to, or characterized by asepsis.
 cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry flow cytometry (flōˑ sī·tˑ·m  laboratories.

This press release is available on the company's official online Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN@agoracom.com, where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.

About Bio-Matrix Scientific Group, Inc.

Bio-Matrix Scientific Group, Inc. (www.BMSNonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.

The Company aligns itself with strategic partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation, and is building a state-of-the-art facility in San Diego, Calif., to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.

DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 20, 2006
Words:410
Previous Article:TRC Announces Expected Timeframe for Filing of Fiscal 2006 10-K.
Next Article:Hitachi Consulting Intensifies Focus on Aerospace and Defense.
Topics:



Related Articles
UCLA ENTERS RACE FOR STEM-CELL MONEY.
Bio-Matrix Announces Contract with Emergo Group Inc. for FDA cGMP/cGTP Compliance and ISO 13485:2003 Certification.
Bio-Matrix Files US and International Utility Patents on Its Stem Cell Extraction Medical Devices.
Bio-Matrix Scientific Group Inc. Announces New Website Address.
Bio-Matrix Scientific Group Inc. Starts Final Phase of Class 10,000 Processing Laboratory Installation.
Bio-Matrix Scientific Group Inc. Update on Class 10,000 Stem Cell Banking and Cellular Tissue Processing Laboratories.
Bio-Matrix Scientific Group Inc. Attends American Society of Plastic Surgeons Conference Held October 6 - 11 in San Francisco.
Bio-Matrix Scientific Group Inc. Processing Laboratory Nearing Completion.
Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived from Fat and Medical Devices Aimed at Plastic Surgeons...
Three new journals from Institute of Physics.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles